The Patent Finder
MN

Multiplicom N.V.

First filing 2014
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 9 US patents in force on its record. from the record

Of the 9 now held by other companies, 9 name Agilent Technologies Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2017 to 2039.
US 9,994,906 Fetal Chromosomal Aneuploidy Diagnosis Oct 18, 2032
US 10,767,228 Fetal Chromosomal Aneuploidy Diagnosis Oct 18, 2032
US 9,598,730 Fetal Chromosomal Aneuploidy Diagnosis Aug 24, 2033
US 10,435,750 Methods for Non-Invasive Detection of Transplant Health or Rejection Jul 3, 2035
US 11,072,829 Methods for Non-Invasive Detection of Transplant Health or Rejection Jul 3, 2035
US 11,926,870 Restriction Mediated Quantitative Polymerase Chain Reactions Jun 16, 2036
US 10,947,588 Restriction Mediated Quantitative Polymerase Chain Reactions Dec 18, 2036
US 11,155,854 Method and System for Estimating a Gender of a Foetus of a Pregnant Female May 5, 2037
US 11,578,357 Modified Multiplex and Multistep Amplification Reactions and Reagents Therefor Jul 4, 2039
20222027203220372039
Every computed term in this portfolio is shown above.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 22 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2035.
Ends Jul 2035 · High confidence
Also notable
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
Ends Oct 2032 · High confidence
Also notable
The newest of the three, granted 2021. It anchors the portfolio to 2036, later than anything else here.
Ends Dec 2036 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 9 patents in force now held by others · 1 patent ended. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited